NEW META-ANALYSIS OF PATIENT-LEVEL DATA ON EFFICACY AND HYPOGLYCAEMIA WITH INSULIN GLARGINE OR NPH INSULIN IN TYPE 2 DIABETES MELLITUS (T2DM) ACCORDING TO CONCOMITANT ORAL THERAPY

被引：2

作者：

Owens, D. R. ^{[1
]}

Trayor, L. ^{[2
]}

Landgraf, W. ^{[3
]}

Mullins, P. ^{[4
]}

机构：

[1] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales

[2] Sanofi US Inc, Bridgewater, NJ USA

[3] Sanofi, Frankfurt, Germany

[4] Univ Auckland, Dept Stat, Auckland 1, New Zealand

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 07期

关键词：

D O I：

10.1016/j.jval.2014.08.644

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PDB22

引用

页码：A335 / A335

页数：1

共 50 条

[1] Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy
Owens, David R.
Traylor, Louise
Mullins, Peter
Landgraf, Wolfgang
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 57 - 65
[2] Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
Home, P. D.
Fritsche, A.
Schinzel, S.
Massi-Benedetti, M.
[J]. DIABETES OBESITY & METABOLISM, 2010, 12 (09): : 772 - 779
[3] Meta-analysis of Clinical Outcomes According to Age in T2DM Patients Initiating Insulin Glargine
Haak, Thomas J.
Traylor, Louise
Landgraf, Wolfgang
Owens, David R.
[J]. DIABETES, 2015, 64 : A256 - A257
[4] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
Raskin, P.
Tanenberg, R. J.
Vlajnic, A.
Hollander, P.
[J]. DIABETOLOGIA, 2007, 50 : S405 - S406
[5] Hypoglycemia as a Function of HbA1c in Type 2 Diabetes (T2DM): Insulin Glargine 300 U/mL in a Patient-Level Meta-analysis of EDITION 1, 2, and 3
Bonadonna, Riccardo C.
Yale, Jean-Francois
Brulle-Wohlhueter, Claire
Corfec, Emmanuelle Boelle-Le
Choudhary, Pratik
Bailey, Timothy S.
[J]. DIABETES, 2016, 65 : A239 - A239
[6] Efficacy and safety of insulin glargine added to ongoing therapy with multiple oral antidiabetic drugs (OADs) in patients with type 2 diabetes mellitus (T2DM)
Davidson, Mayer B.
Raskin, Philip
Tanenberg, Robert
Vlajnic, Aleksandra
Hollander, Priscilla
[J]. DIABETES, 2007, 56 : A542 - A542
[7] Confirmed lower risk of hypoglycaemia with insulin glargine versus NPH insulin:: a meta-analysis of 2304 patients with Type 2 diabetes.
Rosenstock, J
Benedetti, MM
Häring, HU
Lin, Z
Salzman, A
[J]. DIABETOLOGIA, 2003, 46 : A304 - A304
[8] 2-year glycemic control following initiation of insulin glargine versus NPH insulin in individuals with type 2 diabetes (T2DM)
J, Leahy
Dain, M. P.
Rhoads, G. G.
Kennedy, L.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A257 - A258
[9] Safety and efficacy of insulin glargine compared with NPH insulin in older adults with type 2 diabetes mellitus
Lee, P. G.
Chang, A. M.
Blaum, C.
Vlajnic, A.
Miller, M. F.
Halter, J. B.
[J]. DIABETOLOGIA, 2009, 52 : S382 - S382
[10] Local Tolerability of Insulin Degludec is Comparable to Insulin Glargine: A Meta-Analysis of T1DM and T2DM
Meneghini, Luigi F.
Schumm-Draeger, Petra-Maria
Harris, Stewart
Gall, Mari-Anne
Lassota, Nathan
Christiansen, Jens S.
[J]. DIABETES, 2012, 61 : A230 - A230

← 1 2 3 4 5 →